» Authors » Amir Moghadam-Ahmadi

Amir Moghadam-Ahmadi

Explore the profile of Amir Moghadam-Ahmadi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 127
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Rahmani M, Shamsizadeh A, Moghadam-Ahmadi A, Bazmandegan G, Allahtavakoli M
Biomed Pharmacother . 2018 Jun; 103:1720-1726. PMID: 29864962
Introduction: Stroke is a prevalent disorder which is associated with several complications including inflammation. JZL-184 (JZL) inhibits arachidonic acid (AA) production and consequently results in two-arachidonoylglycerol (2-AG) accumulation. Both reduced...
12.
Vakilian A, Razavi-Nasab S, Ravari A, Mirzaei T, Moghadam-Ahmadi A, Jalali N, et al.
Neuroimmunomodulation . 2018 Mar; 24(6):310-319. PMID: 29558759
Introduction: Patients with Alzheimer disease (AD) suffer from psychotic symptoms including pain. The current antipsychotic drugs confer limited effectiveness, and hence new strategies are being designed to decrease pain in...
13.
Rahmani M, Shamsizadeh A, Moghadam-Ahmadi A, Kaeidi A, Allahtavakoli M
Life Sci . 2018 Mar; 198:143-148. PMID: 29496497
Introduction: Investigators are searching to find new therapeutic strategies to reduce stroke secondary injury. JZL-184 (JZL) is an inhibitory factor for production of arachidonic acid (AA). Thus, it suppresses production...
14.
Hakimizadeh E, Shamsizadeh A, Roohbakhsh A, Arababadi M, Hajizadeh M, Shariati M, et al.
Iran J Basic Med Sci . 2017 Nov; 20(8):863-869. PMID: 29085577
Objectives: Stroke is known as a main cause of mortality and prolonged disability in adults. Both transient receptor potential V1 (TRPV1) channels and toll-like receptors (TLRs) are involved in mediating...
15.
Ayoobi F, Shamsizadeh A, Fatemi I, Vakilian A, Allahtavakoli M, Hassanshahi G, et al.
Iran J Basic Med Sci . 2017 Sep; 20(6):604-612. PMID: 28868116
The L. (Yarrow) is a common herb which is widely being used, worldwide. is being used for treatment of many disorders since centuries. It is considered safe for supplemental use...
16.
Almasi-Doghaee M, Boostani R, Saeedi M, Ebrahimzadeh S, Moghadam-Ahmadi A, Saeedi-Borujeni M
Iran J Neurol . 2016 Sep; 15(3):173-4. PMID: 27648179
No abstract available.
17.
Vakilian A, Moghadam-Ahmadi A, Farahmand H
Iran J Neurol . 2016 May; 15(1):57-9. PMID: 27141278
No abstract available.
18.
Anbiaee N, Tafakhori Z, Moghadam-Ahmadi A, Akbarian G
Iran J Radiol . 2015 Apr; 12(2):e8260. PMID: 25901265
Hyperparathyroidism is an endocrine abnormality that frequently causes diffuse osteopenia in the bones. Osteosclerosis is a rare phenomenon in adults with primary hyperparathyroidism since the usual skeletal manifestation is generalized...
19.
Allahtavakoli M, Hosseini Kahnouei M, Rezazadeh H, Roohbakhsh A, Mahmoodi M, Moghadam-Ahmadi A, et al.
Iran J Basic Med Sci . 2014 Nov; 17(7):476-82. PMID: 25429337
Objectives: Hypothermia and decompressive craniectomy (DC) have been shown to be neuroprotective. This study was designed to evaluate neuroprotective effects of delayed singular or combination of DC and local hypothermia...